STARD8 antibody
Quick Overview for STARD8 antibody (ABIN7119500)
Target
See all STARD8 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Purpose
- STARD8 antibody
-
Purification
- Immunogen affinity purified
-
Purity
- ≥95 % as determined by SDS-PAGE
-
Immunogen
- StAR-related lipid transfer(START) domain containing 8
-
Isotype
- IgG
-
-
-
-
Application Notes
- WB: 1:500-1:2000, IHC: 1:20-1:200
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- PBS with 0.02 % sodium azide and 50 % glycerol pH 7.3,
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handling Advice
- Avoid repeated freeze / thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- -20°C for 12 months
-
Expiry Date
- 12 months
-
-
- STARD8 (StAR-Related Lipid Transfer (START) Domain Containing 8 (STARD8))
-
Alternative Name
- STARD8
-
Background
-
Synonyms: StAR-related lipid transfer protein 8|Deleted in liver cancer 3 protein (DLC-3)|START domain-containing protein 8 (StARD8)|START-GAP3|STARD8|DLC3|KIAA0189
Background: Accelerates GTPase activity of RHOA and CDC42, but not RAC1. Stimulates the hydrolysis of phosphatidylinositol 4,5-bisphosphate by PLCD1.
-
Molecular Weight
- 115-120 kDa
-
Gene ID
- 9754
-
UniProt
- Q92502
Target
-